Apolipoproteins: New players in cancers

The plasma lecithin:cholesterol acyltransferase reaction

Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,409 · see citing works

Receptor-Mediated Endocytosis: Concepts Emerging from the LDL Receptor System

Goldstein, J. L., Brown, M. S., Anderson, R. G. W., Russell, D. W., & Schneider, W. J. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.000245 · Cited by 1,600 · see citing works

Plasma lipoproteins: apolipoprotein structure and function.

Mahley, R. W., Innerarity, T. L., Rall, S. C., & Weisgraber, K. H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34443-6 · Cited by 1,155 · see citing works

Therapeutic Nanoparticles and Their Targeted Delivery Applications

Yetisgin, A. A., Çetinel, S., Zuvin, M., Koşar, A., & Kutlu, Ö. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,103 · see citing works

APOE and Alzheimer’s disease: Advances in genetics, pathophysiology, and therapeutic approaches

Serrano-Pozo, A., Das, S., & Hyman, B. T. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30412-9 · Cited by 1,037 · see citing works

The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function.

Segrest, J., Jones, M., Loof, H. D., Brouillette, C. G., Venkatachalapathi, Y. V., & Anantharamaiah, G. M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41536-6 · Cited by 868 · see citing works

Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases

Huang, Y., & Mahley, R. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.025 · Cited by 829 · see citing works

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801 · see citing works

LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer

Tavazoie, M. F., Pollack, I., Tanqueco, R., Ostendorf, B. N., Reis, B. S., Gonsalves, F. C., Kurth, I., Andreu-Agullo, C., Derbyshire, M. L., Posada, J., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.026 · Cited by 476 · cited 1× · see citing works

Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery

Oller‐Salvia, B., Sánchez‐Navarro, M., Giralt, E., & Teixidò, M. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00076b · Cited by 443 · see citing works

Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis

Pencheva, N., Tran, H., Buss, C., Huh, D., Drobnjak, M., Busam, K., & Tavazoie, S. F. (2012) · Cell · doi:10.1016/j.cell.2012.10.028 · Cited by 415 · see citing works

Cancer drug delivery in the nano era: An overview and perspectives

Li, Z., Tan, S., Li, S., Shen, Q., & Wang, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5718 · Cited by 407 · see citing works

Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E

Zheng, P., Luo, Q., Wang, W., Li, J., Wang, T., Wang, P., Chen, L., Zhang, P., Chen, H., Liu, Y., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0465-5 · Cited by 381 · see citing works

Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.

Borén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · see citing works

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288 · see citing works

Human Apolipoprotein B: Structure of Carboxyl-Terminal Domains, Sites of Gene Expression, and Chromosomal Localization

Knott, T. J., Rall, S. C., Innerarity, T. L., Jacobson, S. F., Urdea, M. S., Levy-Wilson, B., Powell, L. M., Pease, R. J., Eddy, R. L., Nakai, H., et al. (1985) · Science · doi:10.1126/science.2994225 · Cited by 277 · see citing works

Apolipoproteins in vascular biology and atherosclerotic disease

Mehta, A., & Shapiro, M. D. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00613-5 · Cited by 273 · see citing works

ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins

Oram, J. F., & Vaughan, A. M. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00005 · Cited by 266 · see citing works

Characterization of the major apolipoproteins secreted by two human hepatoma cell lines

Zannis, V. I., Breslow, J. L., Sangiacomo, T. R., Aden, D. P., & Knowles, B. B. (1981) · Biochemistry · doi:10.1021/bi00528a006 · Cited by 258 · see citing works

Apolipoproteins: metabolic role and clinical biochemistry applications

Dominiczak, M. H., & Caslake, M. J. (2011) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011111 · Cited by 238 · see citing works

Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism

Wolska, A., Dunbar, R. L., Freeman, L. A., Ueda, M., Amar, M. J., Sviridov, D. O., & Remaley, A. T. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.025 · Cited by 231 · see citing works

Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins

Saito, H., Lund‐Katz, S., & Phillips, M. C. (2004) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.05.002 · Cited by 216 · see citing works

FTO Suppresses Glycolysis and Growth of Papillary Thyroid Cancer via Decreasing Stability of APOE mRNA in an N6-Methyladenosine-Dependent Manner

Huang, J., Sun, W., Wang, Z., Lv, C., Zhang, T., Zhang, D., Dong, W., Shao, L., He, L., Ji, X., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02254-z · Cited by 198 · see citing works

Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1

Kemp, S. B., Carpenter, E. S., Steele, N. G., Donahue, K. L., Nwosu, Z. C., Pacheco, A., Velez-Delgado, A., Menjivar, R. E., Lima, F., The, S., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3929 · Cited by 197 · see citing works

Lipid Transport Biochemistry and Its Role in Energy Production

Ryan, R. O., & HORST, D. J. V. D. (2000) · Annual Review of Entomology · doi:10.1146/annurev.ento.45.1.233 · Cited by 190 · see citing works

Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes

Qu, J., Ko, C., Tso, P., & Bhargava, A. (2019) · Cells · doi:10.3390/cells8040319 · Cited by 186 · see citing works

The arterial microenvironment: the where and why of atherosclerosis

Yurdagul, A., Finney, A. C., Woolard, M. D., & Orr, A. W. (2016) · Biochemical Journal · doi:10.1042/bj20150844 · Cited by 185 · see citing works

Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma

Nault, J., Martin, Y., Caruso, S., Hirsch, T., Bayard, Q., Calderaro, J., Charpy, C., Copie-Bergman, C., Ziol, M., Bioulac-Sage, P., et al. (2020) · Hepatology · doi:10.1002/hep.30811 · Cited by 176 · see citing works

Brain‐Targeted Aggregation‐Induced‐Emission Nanoparticles with Near‐Infrared Imaging at 1550 nm Boosts Orthotopic Glioblastoma Theranostics

Wang, J., Liu, Y., Morsch, M., Lu, Y., Shangguan, P., Han, L., Wang, Z., Chen, X., Song, C., Liu, S., et al. (2022) · Advanced Materials · doi:10.1002/adma.202106082 · Cited by 163 · see citing works

Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma

Chen, J., Chen, L., Yang, R.-B., Xia, Y.-L., Zhou, H., Wu, W., Yin, L., Hu, L., & Zhao, Y. (2013) · Medical Oncology · doi:10.1007/s12032-013-0583-y · Cited by 148 · see citing works

Discovery of Novel Bladder Cancer Biomarkers by Comparative Urine Proteomics Using iTRAQ Technology

Chen, Y., Chen, C., Chen, H., Chung, T., Wu, C., Chen, C.-D., Hsu, C., Chen, M.-C., Tsui, K.-H., Chang, P., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100576x · Cited by 148 · see citing works

Apolipoprotein C‐II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway

Wang, C., Yang, Z., Xu, E., Shen, X., Wang, X., Li, Z., Heng, Y., Chen, K., Hu, Q., Xia, X., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.522 · Cited by 147 · see citing works

Apolipoproteins and cancer

Ren, L., Yi, J., Li, W., Zheng, X., Liu, J., Wang, J., & Du, G. (2019) · Cancer Medicine · doi:10.1002/cam4.2587 · Cited by 145 · see citing works

Pro-inflammatory and proliferative microglia drive progression of glioblastoma

Liu, H., Sun, Y., Zhang, Q., Jin, W., Gordon, R. E., Zhang, Y., Wang, J., Sun, C., Wang, Z., Qi, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109718 · Cited by 144 · see citing works

The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles

Kim, S. K., Foote, M. B., & Huang, L. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.010 · Cited by 136 · see citing works

Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy

He, W., Li, X., Morsch, M., Ismail, M., Liu, Y., Rehman, F. U., Zhang, D., Wang, Y., Zheng, M., Chung, R. S., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c00320 · Cited by 116 · see citing works

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma

Grafals‐Ruiz, N., Ríos-Vicil, C. I., Lozada-Delgado, E. L., Quiñones‐Díaz, B. I., Rivera, R. A. N., Martínez-Zayas, G., Santana‐Rivera, Y., Santiago-Sánchez, G. S., Valiyeva, F., & Vivas‐Mejía, P. E. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s241055 · Cited by 110 · see citing works

Common germline variants of the human APOE gene modulate melanoma progression and survival

Ostendorf, B. N., Bilanovic, J., Adaku, N., Tafreshian, K. N., Tavora, B., Vaughan, R. D., & Tavazoie, S. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0879-3 · Cited by 108 · see citing works

Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression

Andreu, Z., Otta, R. J., Redruello, A., López‐Martín, S., Gutiérrez‐Vázquez, C., Morato, E., Marina, A., Gómez, C. O., & Yáñez‐Mó, M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.10.008 · Cited by 107 · see citing works

Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide

Re, F., Cambianica, I., Sesana, S., Salvati, E., Cagnotto, A., Salmona, M., Couraud, P., Moghimi, S. M., Masserini, M., & Sancini, G. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.06.037 · Cited by 102 · see citing works

Tumor-Induced Hyperlipidemia Contributes to Tumor Growth

Huang, J., Li, L., Lian, J., Schauer, S., Vesely, P. W., Kratky, D., Höefler, G., & Lehner, R. S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.020 · Cited by 99 · see citing works

Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Gui, X., Deng, M., Song, H., Chen, Y., Xie, J., Li, Z., He, L., Huang, F., Xu, Y., Anami, Y., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0036 · Cited by 98 · see citing works

ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3

Li, Y.-L., Wu, L., Zeng, L., Zhang, Z., Wang, W., Zhang, C., & Lin, N. (2020) · Oncogene · doi:10.1038/s41388-020-01428-3 · Cited by 90 · see citing works

Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer

Pires, L. A., Hegg, R., Freitas, F. R., Tavares, E. R., de Almeida, C. P., Baracat, E. C., & Maranhão, R. C. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500068 · Cited by 90 · see citing works

Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms

Honda, K., Kobayashi, M., Okusaka, T., Rinaudo, J. A., Huang, Y., Marsh, T. L., Sanada, M., Sasajima, Y., Nakamori, S., Shimahara, M., et al. (2015) · Scientific Reports · doi:10.1038/srep15921 · Cited by 89 · see citing works

Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer

Sirniö, P., Väyrynen, J. P., Klintrup, K., Mäkelä, J. T., Mäkinen, M. J., Karttunen, T. J., & Tuomisto, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-05415-9 · Cited by 86 · see citing works

Apolipoprotein E Overexpression Is Associated With Tumor Progression and Poor Survival in Colorectal Cancer

Zhao, Z., Zou, S., Guan, X., Wang, M., Jiang, Z., Liu, Z., Li, C., Lin, H., Liu, X., Yang, R., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00650 · Cited by 85 · see citing works

Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer

Su, W.-P., Chen, Y.-T., Lai, W.-W., Lin, C.-C., Yan, J.-J., & Su, W.-C. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.04.009 · Cited by 81 · see citing works

TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation

Sun, Y., Ren, D., Yang, C., Yang, W., Zhao, J., Zhou, Y., Jin, X., & Wu, H. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166213 · Cited by 79 · see citing works

Apolipoprotein C1 ( APOC 1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial

Ko, H., Wang, Y., Fong, W., Chi, M., Chi, K., & Kao, S. (2014) · Thoracic Cancer · doi:10.1111/1759-7714.12117 · Cited by 73 · see citing works

Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis

Li, C., Li, H., Zhang, T., Li, J., Liu, L., & Chang, J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.053 · Cited by 72 · see citing works

Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer

Ren, H., Chen, Z., Yang, L., Xiong, W., Yang, H., Xu, K., Zhai, E., Ding, L., He, Y., & Song, X. (2019) · Cancer Management and Research · doi:10.2147/cmar.s192529 · Cited by 72 · see citing works

D‐4F, an apoA‐I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD

Ganapathy, E., Su, F., Meriwether, D., Devarajan, A., Grijalva, V. R., Gao, F., Chattopadhyay, A., Anantharamaiah, G. M., Navab, M., Fogelman, A. M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26079 · Cited by 71 · see citing works

Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo

Zhang, Z., Xin, X., Liu, C., Liu, Y., Duan, H., Qi, L., Zhang, Y., Zhao, H., Chen, L., Jin, M., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01097-8 · Cited by 70 · see citing works

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways

Gao, F., Vasquez, S. X., Su, F., Roberts, S., Shah, N., Grijalva, V. R., Imaizumi, S., Chattopadhyay, A., Ganapathy, E., Meriwether, D., et al. (2011) · Integrative Biology · doi:10.1039/c0ib00147c · Cited by 69 · see citing works

Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection

Ma, X., Gao, X., Gong, Z., Wu, J., Tian, L., Zhang, C., Zhou, Y., Sun, Y., Hu, B., Qiu, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12203 · Cited by 69 · see citing works

Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study

Hemelrijck, M. V., Walldius, G., Jungner, I., Hammar, N., Garmo, H., Binda, E., Hayday, A., Lambe, M. P., & Holmberg, L. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9774-z · Cited by 69 · see citing works

APOE polymorphisms and cognitive functions in patients with brain tumors

Correa, D. D., Satagopan, J. M., Baser, R. E., Cheung, K., Richards, E. A., Lin, M., Karimi, S., Lyo, J. K., DeAngelis, L. M., & Orlow, I. (2014) · Neurology · doi:10.1212/wnl.0000000000000617 · Cited by 63 · see citing works

Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness

Revilla, G., Pons, M. D. P., Baila-Rueda, L., García‐León, A., Santos, D., Cenarro, A., Magalhães, M., Blanco, R., Moral, A., Pérez, J. I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46727-2 · Cited by 63 · see citing works

Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer

Ma, M.-Z., Yuan, S., Chen, Y.-M., & Zhou, Z.-W. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s156690 · Cited by 62 · see citing works

Liver cell-targeted delivery of therapeutic molecules

Kang, J., Toita, R., & Murata, M. (2014) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2014.930017 · Cited by 60 · see citing works

CA19‐9 and apolipoprotein‐A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation

Honda, K., Katzke, V. A., Hüsing, A., Okaya, S., Shoji, H., Onidani, K., Olsen, A., Tjønneland, A. M., Overvad, K., Weiderpass, E., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31900 · Cited by 59 · see citing works

Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer

Yi, J., Ren, L., Wu, J., Li, W., Zheng, X., Du, G., & Wang, J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.59 · Cited by 56 · see citing works

ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer

Li, J., Gao, A., Zhang, F., Wang, S., Wang, J., Wang, J., Han, S., Yang, Z., Chen, X., Fang, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.048 · Cited by 55 · see citing works

Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases

Mahley, R. W. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255695 · Cited by 53 · see citing works

Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis

Saadat, M. (2012) · Cancer Research and Treatment · doi:10.4143/crt.2012.44.2.121 · Cited by 52 · see citing works

The Valuable Role of Measuring Serum Lipid Profile in Cancer Progression

Ghahremanfard, F., Mirmohammadkhani, M., Shahnazari, B., Gholami, G., & Mehdizadeh, J. (2015) · Oman Medical Journal · doi:10.5001/omj.2015.71 · Cited by 52 · see citing works

Oncogene APOL1 promotes proliferation and inhibits apoptosis via activating NOTCH1 signaling pathway in pancreatic cancer

Lin, J., Xu, Z., Xie, J., Deng, X., Jiang, L., Chen, H., Peng, C., Li, H., Zhang, J., & Shen, B. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03985-1 · Cited by 52 · see citing works

ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy

Wei, J., Wu, D., Shao, Y., Guo, B., Jiang, J., Chen, J., Zhang, J., Meng, F., & Zhong, Z. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.048 · Cited by 52 · see citing works

Clinical significance of APOB inactivation in hepatocellular carcinoma

Lee, G., Jeong, Y. S., Kim, D. W., Kwak, M. J., Koh, J., Joo, E. W., Lee, J., Kah, S., Sim, Y.-E., & Yim, S. Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0174-2 · Cited by 51 · see citing works

The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway

Zhang, H., Wang, Y., Liu, C., Li, W., Zhou, F., Wang, X., & Zheng, J. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153746 · Cited by 50 · see citing works

Apolipoprotein M

Ren, K., Tang, Z., Jiang, Y., Tan, Y., & Yi, G. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.03.038 · Cited by 50 · see citing works

Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice

Qin, H., Jiang, Y., Zhang, J., Deng, C., & Zhong, Z. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00691 · Cited by 49 · see citing works

Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro

Su, W., Sun, L., Yang, S., Zhao, H., Zeng, T., Wu, W., & Wang, D. (2018) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22158 · Cited by 48 · see citing works

Apolipoprotein mimetics in cancer

Delk, S. C., Chattopadhyay, A., Escolá‐Gil, J. C., Fogelman, A. M., & Reddy, S. T. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.002 · Cited by 47 · see citing works

Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer

Jiang, C., Wang, X., Teng, B., Wang, Z., Li, F., Zhao, Y., Guo, Y., & Zeng, Q. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c02074 · Cited by 46 · see citing works

Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays

Kupervaser, M., Yossef, R., Erez, T., Kugel, A., Welt, M., Karpasas, M. M., Bones, J., Rudd, P. M., Taı̈eb, J., Boissin, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014540 · Cited by 46 · see citing works

Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma

Cui, Y., Miao, C., Hou, C., Wang, Z., & Liu, B. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01436 · Cited by 46 · see citing works

A case–control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression

Feo, E. D., Simone, B., Persiani, R., Cananzi, F., Biondi, A., Arzani, D., Amore, R., D’Ugo, D., Ricciardi, G., & Boccia, S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-494 · Cited by 45 · see citing works

Apolipoprotein D—An atypical apolipoprotein

WEECH, P. K., Provost, P. R., Tremblay, N. M., Camato, R., Milne, R. W., Marcel, Y. L., & Rassart, É. (1991) · Progress in Lipid Research · doi:10.1016/0163-7827(91)90023-x · Cited by 45 · see citing works

Cadmium-induced malignant transformation of rat liver cells: Potential key role and regulatory mechanism of altered apolipoprotein E expression in enhanced invasiveness

Suzuki, M., Takeda, S., Teraoka-Nishitani, N., 山縣あかね, Tanaka, T., Sasaki, M., Yasuda, N., Oda, M., Okano, T., Yamahira, K., et al. (2017) · Toxicology · doi:10.1016/j.tox.2017.03.014 · Cited by 44 · see citing works

Apolipoprotein A1 and B as risk factors for development of intraocular metastasis in patients with breast cancer

Liu, J., Yuan, Q., Min, Y., He, Y., Xu, Q., Li, B., Shi, W., Lin, Q., Li, Q., Zhu, P., et al. (2019) · Cancer Management and Research · doi:10.2147/cmar.s191352 · Cited by 43 · see citing works

Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer

Luo, J., Song, J., Feng, P., Wang, Y., Long, W., Liu, M., & Li, L. (2016) · Tumor Biology · doi:10.1007/s13277-016-4975-4 · Cited by 42 · see citing works

Glycoproteomic identification of novel plasma biomarkers for oral cancer

Chang, S.-C. S., Lin, W.-L., Chang, Y., Lee, C., Wu, J., Hsu, P., & Chang, C. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.12.008 · Cited by 41 · see citing works

Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients

Jankovic‐Karasoulos, T., Bianco‐Miotto, T., Butler, M. S., Butler, L. M., McNeil, C. M., O’Toole, S. A., Millar, E. K. A., Sakko, A. J., Ruiz, A. I., Birrell, S. N., et al. (2020) · Histopathology · doi:10.1111/his.14081 · Cited by 41 · see citing works

Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer

CHEN, J., WU, W., ZHEN, C., ZHOU, H., YANG, R., CHEN, L., & HU, L. (2013) · Oncology Letters · doi:10.3892/ol.2013.1326 · Cited by 40 · see citing works

ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer

Cedó, L., García‐León, A., Baila-Rueda, L., Santos, D., Grijalva, V. R., Martínez-Cignoni, M. R., Carbo, J. M. C. I., Metso, J., López-Vilaró, L., Zorzano, A., et al. (2016) · Scientific Reports · doi:10.1038/srep36387 · Cited by 39 · see citing works

Diagnostic and prognostic significance of mRNA expressions of apolipoprotein A and C family genes in hepatitis B virus‐related hepatocellular carcinoma

Wang, X., Gong, Y., Deng, T., Zhang, L., Liao, X., Han, C., Yang, C., Huang, J., Wang, Q., Song, X., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29131 · Cited by 38 · see citing works

Apolipoprotein C2 - CD36 Promotes Leukemia Growth and Presents a Targetable Axis in Acute Myeloid Leukemia

Zhang, T., Yang, J., Vaikari, V. P., Beckford, J., Wu, S. K., Akhtari, M., & Alachkar, H. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-19-0077 · Cited by 38 · see citing works

Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism

Liu, Y., & Morton, R. E. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000688 · Cited by 38 · see citing works

Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression

Peng, M., Zhang, Q., Cheng, Y., Fu, S., Yang, H., Guo, X., Zhang, J., Wang, L., Zhang, L., Xue, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21157 · Cited by 38 · see citing works

Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population

Kang, R., Li, P., Wang, T., Li, X., Wei, Z., Zhang, Z., Zhong, L., Cao, L., Heckman, M. G., Zhang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep19930 · Cited by 37 · see citing works

FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer

Lai, H., Zhao, X., Yu, Q., Ding, Y., Chen, R., Li, G., Labrie, M., Ding, Z., Zhou, J., Hu, J., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0696-4 · Cited by 37 · see citing works

Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer

Chattopadhyay, A., Yang, X., Mukherjee, P., Sulaiman, D., Fogelman, H. R., Grijalva, V. R., Dubinett, S. M., Wasler, T. C., Paul, M. K., Salehi‐Rad, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26755-0 · Cited by 37 · see citing works

Apolipoprotein E Promotes Invasion in Oral Squamous Cell Carcinoma

Jayakar, S. K., Loudig, O. D., Brandwein‐Gensler, M. S., Kim, R. S., Ow, T. J., Ustun, B., Harris, T. M., Prystowsky, M. B., Childs, G. J., Segall, J. E., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.06.016 · Cited by 35 · see citing works

Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis

Ifere, G. O., Desmond, R. A., Demark‐Wahnefried, W., & Nagy, T. R. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2057 · Cited by 34 · see citing works

Expression and potential role of apolipoprotein D on the death–survival balance of human colorectal cancer cells under oxidative stress conditions

Bajo‐Grañeras, R., Crespo-Sanjuán, J., García-Centeno, R. M., Garrote, J. A., Gutiérrez, G., García-Tejeiro, M., Gervás, B. A., Nieves, M. D. C., Bustamante, R., Ganfornina, M. D., et al. (2013) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1616-2 · Cited by 34 · see citing works

Apolipoprotein-mediated regulation of lipid metabolism induces distinctive effects in different types of breast cancer cells

Hassen, C. B., Gutiérrez-Pajares, J. L., Guimaraes, C., Guibon, R., Pinault, M., Fromont, G., & Frank, P. G. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01276-9 · Cited by 33 · see citing works

Ginsenoside-Rp1-induced apolipoprotein A-1 expression in the LoVo human colon cancer cell line

Kim, M., Yoo, B. C., & Cho, J. Y. (2014) · Journal of Ginseng Research · doi:10.1016/j.jgr.2014.06.003 · Cited by 32 · see citing works

The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma

Guo, S., He, X., Chen, Q., Yang, G., Yao, K., Dong, P., Ye, Y., Chen, D., Zhang, Z., Qin, Z., et al. (2016) · Medicine · doi:10.1097/md.0000000000003147 · Cited by 32 · see citing works

Apolipoprotein M promotes proliferation and invasion in non-small cell lung cancers via upregulating S1PR1 and activating the ERK1/2 and PI3K/AKT signaling pathways

Zhu, Y., Luo, G., Jiang, B., Yu, M., Feng, Y., Wang, M. T., Xu, N., & Zhang, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.029 · Cited by 32 · see citing works

The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer

Wang, Y., Chen, Z., Chen, J., Pan, J., Zhang, W., Pan, Q., Ding, H., Lin, X., Wen, X., Li, Y., et al. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.03.013 · Cited by 32 · see citing works

Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency

Li, W., Fu, J., Ding, Y., Liu, D., Jia, N., Chen, D., & Hu, H. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.051 · Cited by 32 · see citing works

Identification of a Lipoprotein Lipase Cofactor-binding Site by Chemical Cross-linking and Transfer of Apolipoprotein C-II-responsive Lipolysis from Lipoprotein Lipase to Hepatic Lipase

McIlhargey, T. L., Yang, Y., Wong, H., & Hill, J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300315200 · Cited by 31 · see citing works

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients

Mao, M., Wang, X., Sheng, H., Liu, Y., Zhang, L., Dai, S., & Chi, P. (2018) · BMC Cancer · doi:10.1186/s12885-018-5028-8 · Cited by 31 · see citing works

Vitexin confers HSF-1 mediated autophagic cell death by activating JNK and ApoL1 in colorectal carcinoma cells

Bhardwaj, M., Paul, S., Jakhar, R., Khan, I., Kang, J. I., Kim, H. M., Yun, J. W., Lee, S., Cho, H. J., Lee, H. G., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20113 · Cited by 31 · see citing works

Cadmium-stimulated invasion of rat liver cells during malignant transformation: Evidence of the involvement of oxidative stress/TET1-sensitive machinery

Hirao-Suzuki, M., Takeda, S., Sakai, G., Waalkes, M. P., Sugihara, N., & Takiguchi, M. (2020) · Toxicology · doi:10.1016/j.tox.2020.152631 · Cited by 31 · see citing works

Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer

Shi, X., Wang, J., Dai, S., Qin, L., Zhou, J., & Chen, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s280690 · Cited by 30 · see citing works

Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors

Ghantasala, S., Pai, M. G. J., Biswas, D., Gahoi, N., Mukherjee, S., Manubhai, K. P., Nissa, M. U., Srivastava, A., Epari, S., Shetty, P. M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.548243 · Cited by 30 · see citing works

Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity

Lee, Y. S., Yeo, I. J., Kim, K. C., Han, S., & Hong, J. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01379 · Cited by 29 · see citing works

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer

Marinho, A. T., Lu, H., Pereira, S. A., Monteiro, E. C., Gabra, H., & Recchi, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01524 · Cited by 29 · see citing works

Apolipoprotein A1 −75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer

Hamrita, B., Nasr, H. B., Gabbouj, S., Bouaouina, N., Chouchane, L., & Chahed, K. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0274-0 · Cited by 29 · see citing works

Macrophage apolipoprotein E and proliferation of MCF-7 breast cancer cells: role of LXR.

Roz, A. E., Bard, J., Valin, S., Huvelin, J., & Nazih, H. (2013) · PubMed · Cited by 29 · see citing works

Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma

Yang, R., Zhao, Y., Gu, Y., Yang, Y., Gao, X., Yuan, Y., Xiao, L., Zhang, J., Sun, C., Yang, H. K., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01439-0 · Cited by 28 · see citing works

Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer

Shi, J., Yang, H., Duan, X., Li, L., Sun, L., Li, Q., & Zhang, J. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.3.549 · Cited by 28 · see citing works

Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer

Shi, H. R., Huang, H., Pu, J., Shi, D., Ning, Y., Dong, Y., Han, Y., Zarogoulidis, P., & Bai, C. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s170227 · Cited by 28 · see citing works

Serum Proteomic Signatures of Male Breast Cancer

Zografos, E., Anagnostopoulos, A. K., Papadopoulou, A., Legaki, E., Zagouri, F., Marinos, E., Tsangaris, G. T., & Gazouli, M. (2019) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20118 · Cited by 28 · see citing works

Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma

Xue, A., Chang, J., Chung, L., Samra, J. S., Hugh, T. J., Gill, A. J., Butturini, G., Baxter, R. C., & Smith, R. C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.458 · Cited by 27 · see citing works

Serum levels of apolipoprotein E correlates with disease progression and poor prognosis in breast cancer

Xu, X., Wan, J., Yuan, L., Ba, J., Feng, P., Long, W., Huang, H., Liu, P., Cai, Y., Liu, M., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5453-8 · Cited by 25 · see citing works

Identification of High Serum Apolipoprotein A1 as a Favorable Prognostic Indicator in Patients with Multiple Myeloma

Liang, L., Li, J., Fu, H., Liu, X., & Liu, P. (2019) · Journal of Cancer · doi:10.7150/jca.31357 · Cited by 25 · see citing works

AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux

Zhang, T., Wang, Q., Wang, Y., Wang, J., Su, Y., Wang, F., & Wang, G. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1910-7 · Cited by 25 · see citing works

The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis

Innes, H. A., Nischalke, H. D., Guha, I. N., Weiss, K. H., Irving, W. L., Gotthardt, D. N., Barnes, E. J., Fischer, J., Ansari, M. A., Rosendahl, J., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1886 · Cited by 24 · see citing works

Association of the Apolipoprotein E 2 Allele with Concurrent Occurrence of Endometrial Hyperplasia and Endometrial Carcinoma

Ivanova, T. I., Krikunova, L. I., Ryabchenko, N. I., Сирекановна, М. Л., Алексеевна, Х. В., & Salnikova, L. E. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/593658 · Cited by 24 · see citing works

Associations of Polymorphisms of rs693 and rs1042031 in Apolipoprotein B Gene With Risk of Breast Cancer in Chinese

Liu, X., Wang, Y., Qu, H., Hou, M., Cao, W., Ma, Z., & Wang, H. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt018 · Cited by 24 · see citing works

Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis

Quan, Q., Huang, Y., Chen, Q., Qiu, H., Hu, Q., Rong, Y., Li, T., Xia, L., & Zhang, B. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.006 · Cited by 24 · see citing works

Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma

Yan, X., Yao, M., Wen, X., Zhu, Y., Zhao, E., Qian, X., Chen, X., Lu, W., Lv, Q., Zhang, L., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s192631 · Cited by 24 · see citing works

Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses

Zhang, Z., Qin, K., Zhang, W., Yang, B., Zhao, C., Zhang, X., Zhang, F., Zhao, L., & Shan, B. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0499-z · Cited by 24 · see citing works

Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling

Yu, M., Pan, L., Sang, C., Mu, Q., Zheng, L., Luo, G., & Xu, N. (2019) · Cancer Management and Research · doi:10.2147/cmar.s202799 · Cited by 24 · see citing works

Comprehensive Identification of Potential Crucial Genes and miRNA‐mRNA Regulatory Networks in Papillary Thyroid Cancer

Nan, B., Xiong, G., Zhao, Z., Gu, X., & Huang, X. (2021) · BioMed Research International · doi:10.1155/2021/6752141 · Cited by 24 · see citing works

Proteomic profiling of human plasma identifies apolipoprotein E as being associated with smoking and a marker for squamous metaplasia of the lung

Rice, S. J., Liu, X., Miller, B., Joshi, M., Zhu, J., Caruso, C., Gilbert, C. R., Toth, J. W., Reed, M. F., Rassaei, N., et al. (2015) · PROTEOMICS · doi:10.1002/pmic.201500029 · Cited by 23 · see citing works

Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling

jiang, H., Tang, J., Xue, D., Chen, Y., Wu, T., Zhuang, Q., & He, X. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01713-x · Cited by 23 · see citing works

Prognostic significance of high triglyceride and apolipoprotein B levels in patients with stage III and high-risk stage II colorectal cancer undergoing curative surgery

Chen, X., Wu, P., Liu, D., Yan, S., Shen, X.-M., & Yang, L. (2020) · Oncology Letters · doi:10.3892/ol.2020.11617 · Cited by 22 · see citing works

Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment

An, D., Yu, X., Jiang, L., Wang, R., He, P., Chen, N., Guo, X., Li, X., & Feng, M. (2021) · Molecules · doi:10.3390/molecules26051280 · Cited by 22 · see citing works

Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy

Gong, M., Zhang, Q., Zhao, Q., Zheng, J., Li, Y., Wang, S., & Yuan, Y. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1618420 · Cited by 21 · see citing works

Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc–p21Waf1 signalling pathway

Du, S., Wang, H., Cai, J., Ren, R., Zhang, W., Wei, W., & Shen, X. (2020) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0230 · Cited by 21 · see citing works

Expression of apolipoprotein M in human hepatocellular carcinoma tissues

Jiang, J., Wu, C., Luo, G., Zheng, L., Chen, L., Zhang, X., & Xu, N. (2009) · Acta Histochemica · doi:10.1016/j.acthis.2009.08.005 · Cited by 21 · see citing works

Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes

Hayasaki, A., Murata, Y., Usui, M., Hibi, T., Fujii, T., Iizawa, Y., Kato, H., Tanemura, A., Azumi, Y., Kuriyama, N., et al. (2019) · BioMed Research International · doi:10.1155/2019/5738614 · Cited by 21 · see citing works

Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer

Peng, M., Zhang, Q., Liu, Y., Guo, X., Ju, J., Xu, L., Gao, Y., Chen, D., Mu, D., & Zhang, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00576 · Cited by 21 · see citing works

Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer

Sato, Y., Kobayashi, T., Nishiumi, S., Okada, A., Fujita, T., Sanuki, T., Kobayashi, M., Asahara, M., Adachi, M., Sakai, A., et al. (2020) · Cancers · doi:10.3390/cancers12092625 · Cited by 20 · see citing works

miR‐4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2

Chen, Y., Qin, C., Cui, X., Geng, W., Xian, G., & Wang, Z. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29506 · Cited by 20 · see citing works

A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas

Correa, D. D., Kryza‐Lacombe, M., Zhou, X., Baser, R. E., Beattie, B. J., Beiene, Z., Humm, J. L., DeAngelis, L. M., Orlow, I., Weber, W., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2692-5 · Cited by 19 · see citing works

Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma

Zhang, F., Xie, Y., Ma, X., Gu, L., Li, H., Li, X., Guo, G., & Zhang, X. (2018) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.11.010 · Cited by 19 · see citing works

Plasma proteome plus site‐specific N‐glycoprofiling for hepatobiliary carcinomas

Chang, T., Cheng, J., Tsai, H., Young, K., Hsieh, S., & Ho, C. (2019) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.136 · Cited by 19 · see citing works

Risk factors and their diagnostic values for ocular metastases in invasive ductal carcinoma

Liang, R., Yu, K., Wu, J., Liu, J., Lin, Q., Li, B., Zhang, Y., Ge, Q., Li, Q., Shu, H., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3656 · Cited by 19 · see citing works

Different Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis

Tanaka, T., Oyama, T., Sugie, S., & Shimizu, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111806 · Cited by 19 · see citing works

Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection

Ni, X., Yi, Y., Fu, Y., Cai, X., Liu, G., Huang, J., Gan, W., Xu, J., & Qiu, S. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s279997 · Cited by 19 · see citing works

Apolipoprotein M promotes growth and inhibits apoptosis of colorectal cancer cells through upregulation of ribosomal protein S27a

Mu, Q., Luo, G., Jiang, W., Zheng, L., Wang, H., Yu, M., & Xu, N. (2020) · EXCLI journal · doi:10.17179/excli2020-2867 · Cited by 19 · see citing works

Identifying the role of apolipoprotein A-I in prostate cancer

Wang, J., Xu, L., Liu, C., Huang, T., Liang, C.-Z., & Fan, Y. (2021) · Asian Journal of Andrology · doi:10.4103/aja.aja_92_20 · Cited by 18 · see citing works

Neutrophil-to-Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization

Chen, J., Chen, Y., Jiang, N., Xu, J., Liang, Z., Bai, M., Xing, Y., Liu, Z., Wu, X.-Y., & Li, X. (2021) · The Oncologist · doi:10.1002/onco.13743 · Cited by 18 · see citing works

Secretomes are a potential source of molecular targets for cancer therapies and indicate that APOE is a candidate biomarker for lung adenocarcinoma metastasis

Liu, Z., Gao, Y., Hao, F., Lou, X., Zhang, X., Li, Y., Wu, D., Xiao, T., Yang, L., Li, Q., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3641-4 · Cited by 18 · see citing works

ApoM is an important potential protective factor in the pathogenesis of primary liver cancer

Bai, Y., Pei, W., Zhang, X., Zheng, H.-H., Hua, C., Min, J., Li-sheng, H., Du, S., Gong, Z., Gao, J., et al. (2021) · Journal of Cancer · doi:10.7150/jca.53115 · Cited by 18 · see citing works

Prognostic value of the serum apolipoprotein B to apolipoprotein A-I ratio in metastatic colorectal cancer patients

Yang, D.-D., Chen, Z., Wang, D., Yu, H., Lu, J., Xu, R., & Zeng, Z.-L. (2019) · Journal of Cancer · doi:10.7150/jca.35659 · Cited by 18 · see citing works

A Case-Control Study on the Effect of Apoliprotein E Genotype on Head and Neck Cancer Risk

Feo, E. D., Rowell, J. L., Cadoni, G., Nicolotti, N., Arzani, D., Giorgio, A., Amore, R., Paludetti, G., Ricciardi, G., & Boccia, S. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0624 · Cited by 17 · see citing works

Apolipoprotein C-II Is a Potential Serum Biomarker as a Prognostic Factor of Locally Advanced Cervical Cancer After Chemoradiation Therapy

Harima, Y., Ikeda, K., Utsunomiya, K., Komemushi, A., Kanno, S., Shiga, T., & Tanigawa, N. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.08.023 · Cited by 17 · see citing works

Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients

Shang, Z., Wang, J., Wang, X., Yan, H., Cui, B., Jia, C., Wang, Q., Cui, X., Li, J., & Ou, T. (2018) · Cancer Management and Research · doi:10.2147/cmar.s165213 · Cited by 16 · see citing works

Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study

Harborg, S., Ahern, T. P., Feldt, M., Rosendahl, A. H., Cronin-Fenton, D. P., Melander, O., & Borgquist, S. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06462-7 · Cited by 16 · see citing works

Apolipoprotein E Genotypes in Patients with Prostate Cancer.

Yencilek, F., Yılmaz, S. G., Yıldırım, A., Görmüş, U., Altınkılıç, E. M., Dalan, A. B., Baştuğ, Y., Turkmen, S., Turkan, S., & İşbir, T. (2016) · PubMed · Cited by 16 · see citing works

Apolipoprotein E Polymorphism and Colorectal Neoplasm: Results from a Meta-Analysis

Tian, Y., Wang, J., Ye, Y., Sun, L., Fan, Y., Wang, L., Li, J., Wang, Z., & Wang, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102477 · Cited by 15 · see citing works

Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer

Wang, M., Wang, J., & Jiang, H. (2019) · Oncology Letters · doi:10.3892/ol.2019.9957 · Cited by 15 · see citing works

Construction of a novel mRNA-miRNA-lncRNA network and identification of potential regulatory axis associated with prognosis in colorectal cancer liver metastases

Chen, L., Luo, X., Xing, C., Mao, Y., Xu, Y., Gao, W., Wang, W., Zhan, T., Wang, G., Liu, Z., et al. (2021) · Aging · doi:10.18632/aging.203049 · Cited by 15 · see citing works

Apolipoprotein M inhibits proliferation and migration of larynx carcinoma cells

Xue, H., Yu, M., Zhou, Y. Y., Zhang, J., Mu, Q., Chen, T., Luo, G., & Liu, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-76480-w · Cited by 15 · see citing works

Neutrophil to apolipoprotein A‐I ratio as an independent indicator of locally advanced nasopharyngeal carcinoma

Li, J., Wu, Y., Li, W., & Ma, J. (2021) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.660 · Cited by 14 · see citing works

Novel efficacious microRNA-30c analogs reduce apolipoprotein B secretion in human hepatoma and primary hepatocyte cells

Yadav, P. K., Haruehanroengra, P., Irani, S., Wang, T., Ansari, A., Sheng, J., & Hussain, M. M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101813 · Cited by 14 · see citing works

Apolipoprotein M increases the expression of vitamin D receptor mRNA in colorectal cancer cells detected with duplex fluorescence reverse transcription-quantitative polymerase chain reaction

Yu, M., Yao, S., Luo, K., Mu, Q., Yu, Y., Luo, G., & Xu, N. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6716 · Cited by 14 · see citing works

The effects and possible mechanism of action of apolipoprotein M on the growth of breast cancer cells

Zhou, Y., Yao, S., Yu, M., Jiang, W., Fang, Q., Xu, N., & Luo, G. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06945-2 · Cited by 14 · see citing works

The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma

Zhong, F., Lu, H., Chen, G., Dang, Y., Zhang, X.-G., Liang, Y., Li, M., Li, G., Chen, X.-Y., Yao, Y.-X., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.12240 · Cited by 13 · see citing works

Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC

Xu, J., Wang, L., Yin, N., Chen, A., Yi, J., Tang, J., & Xiang, J. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.14147 · Cited by 13 · see citing works

Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery

Chen, C., Yi, W., Zeng, Z., Wang, Q., Wu, J., Gao, Y., & Chang, H. (2022) · BMC Cancer · doi:10.1186/s12885-021-09101-y · Cited by 13 · see citing works

Tissue expression of glycated apolipoprotein B in colorectal adenoma and cancer.

Reddavide, R., Misciagna, G., Caruso, M. G., Notarnicola, M., Armentano, R., Caruso, M. L., Pirrelli, M., & Valentini, A. M. (2011) · PubMed · Cited by 12 · see citing works

Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis

Nascimento, J. C. R., Pereira, L. C., Rêgo, J. M. D. C., Dias, R. P., Silva, P. G. B., Cândido-Sobrinho, S. A., Coelho, G., Brasil, I. R. C., de Oliveira-Filho, E. F., Owen, J. S., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i11.1064 · Cited by 12 · see citing works

Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms

Honda, K. (2022) · Cancer Biomarkers · doi:10.3233/cbm-210198 · Cited by 12 · see citing works

Expression analysis of apolipoprotein E and its associated genes in gastric cancer

Shi, X., Xu, J., Wang, J., Cui, M., Gao, Y., Niu, H., & Jin, H. (2015) · Oncology Letters · doi:10.3892/ol.2015.3447 · Cited by 12 · see citing works

Serum Apolipoprotein A-I Combined With C-Reactive Protein Serves As A Novel Prognostic Stratification System For Colorectal Cancer

Ye, J., Luo, Q.-Y., Wang, X., Liu, Z., Chen, M., Huang, H., & Zhang, L. (2019) · Cancer Management and Research · doi:10.2147/cmar.s215599 · Cited by 12 · see citing works

Significant Implications of APOA1 Gene Sequence Variations and Its Protein Expression in Bladder Cancer

Magray, J. A., Pandith, A. A., Qasim, I., Khateeb, M., Hamid, A., Koul, A. M., Shah, Z. A., Baba, S. M., Mansoor, S., Charifi, W., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9080938 · Cited by 12 · see citing works

ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells

Zhang, X., Bai, Y., Zhu, W., Lv, X., & Pei, W. (2022) · Oncology Letters · doi:10.3892/ol.2022.13331 · Cited by 12 · see citing works

Liver X Receptor β Related to Tumor Progression and Ribosome Gene Expression in Papillary Thyroid Cancer

Jeong, S., Kim, I., Kim, H., Choi, M. J., Lee, J., & Jo, Y. S. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.667 · Cited by 11 · see citing works

Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells

Li, J., Han, M., Li, J., Ge, Z., Wang, Q., Zhou, K., & Yin, X. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1745330 · Cited by 10 · see citing works

Local ablation of gastric cancer by reconstituted apolipoprotein B lipoparticles carrying epigenetic drugs

Yang, C.-L., Chao, Y., Wang, H., Hou, Y., Chen, C. G., Chang, C., & Shan, Y. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102450 · Cited by 10 · see citing works

Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study

Harima, Y., Ariga, T., Kaneyasu, Y., Ikushima, H., Tokumaru, S., Shimamoto, S., Takahashi, T., Ii, N., Tsujino, K., Saito, A. I., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259235 · Cited by 10 · see citing works

Apolipoprotein A1 is negatively associated with male papillary thyroid cancer patients: a cross-sectional study of single academic center in China

Ma, M., Wang, M., Zhang, Z., Lin, B., Sun, Z., Guan, H., Lv, W., & Li, J. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00714-9 · Cited by 10 · see citing works

Integrated bioinformatics analysis of the association between apolipoprotein E expression and patient prognosis in papillary thyroid carcinoma

Jiang, Q., Feng, W., Xiong, C., & Lv, Y. (2020) · Oncology Letters · doi:10.3892/ol.2020.11316 · Cited by 10 · see citing works

Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer

He, Y., Han, S.-B., Liu, Y., Zhang, J., & Wu, Y. (2022) · BMC Cancer · doi:10.1186/s12885-022-09528-x · Cited by 10 · see citing works

ERα promotes transcription of tumor suppressor gene ApoA-I by establishing H3K27ac-enriched chromatin microenvironment in breast cancer cells

Wang, B., Shen, Y., Liu, T., & Tan, L. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100393 · Cited by 9 · see citing works

Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis

Zheng, X., Chen, W., Yi, J., Wan, L., Liu, J.-Y., Fu, W.-Q., Ren, L., Li, S., Ge, B., Yang, Y., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00969-5 · Cited by 9 · see citing works

Fibroblast growth factor-21, epidermal growth factor receptor, interleukine-6, myeloperoxidase, lipid hydroperoxide, apoAI, apoB concentration, and lipid and lipoprotein ratios, as diagnostic serum biomarkers for gastric cancer

Kimak, E., Nurczyk, K., Skoczylas, T., Duma, D., Gieroba, R., & Solski, J. (2019) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.14836 · Cited by 8 · see citing works

Apolipoprotein L1 is transcriptionally regulated by SP1, IRF1 and IRF2 in hepatoma cells

Wang, D., Yu, Z., He, Z., Liao, J., Shen, X., Zhu, P., Chen, W., Lin, X., & Xu, S. (2020) · FEBS Letters · doi:10.1002/1873-3468.13887 · Cited by 8 · see citing works

Apolipoprotein E2 Promotes the Migration and Invasion of Pancreatic Cancer Cells via Activation of the ERK1/2 Signaling Pathway

Wang, H., Du, S., Cai, J., Wang, J., & Shen, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s284115 · Cited by 8 · see citing works

Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy

Guo, S., Chen, C., Zeng, Z., Wang, Q., Wu, J., Gao, Y., & Chang, H. (2021) · Cancer Management and Research · doi:10.2147/cmar.s302677 · Cited by 8 · see citing works

Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor

Sun, L., Ji, X., Wang, D., Guan, A., Xiao, Y., Xu, H., Du, S., Xu, Y., Zhao, H., Lü, X., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07496-8 · Cited by 8 · see citing works

Identification of Apolipoprotein E as a Potential Diagnostic Biomarker of Nasopharyngeal Carcinoma

Xue, Y., Huang, S., Huang, J., Li, S., Zhang, C., & Zhou, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s239479 · Cited by 7 · see citing works

Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer

Min, Y., Feng, Y., Luo, H., Hu, D., Wei, X., He, D., Yin, G., & Fan, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.824362 · Cited by 7 · see citing works

Prognostic Effect of Preoperative Apolipoprotein B Level in Surgical Patients with Clear Cell Renal Cell Carcinoma

Wang, K., Wu, T., Chen, Y., Song, G., & Chen, Z. (2020) · Oncology Research and Treatment · doi:10.1159/000507964 · Cited by 7 · see citing works

Association of ApoE haplotype with clinical evidence of pituitary adenoma

Sidaraitė, A., Vilkevičiūtė, A., Glebauskienė, B., Kriaučiūnienė, L., Žaliūnienė, D., & Liutkevičienė, R. (2019) · Gene · doi:10.1016/j.gene.2019.04.090 · Cited by 5 · see citing works

Apolipoprotein A1 and Low-Density Lipoprotein as Risk Factors for Intraocular Metastases in Postmenopausal Breast Cancer

Li, B., Liu, Y., Yuan, Q., Lin, Q., Shi, W., Zhu, P., Min, Y., Ge, Q., & Shao, Y. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820984180 · Cited by 4 · see citing works

The Prognostic Impact of Preoperative Serum Apolipoprotein A-I in Patients with Esophageal Basaloid Squamous Cell Carcinoma

Feng, J., Zhao, J., Yang, X., & Wang, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s328138 · Cited by 4 · see citing works

Lipid metabolism in homeostasis and disease

Li, Z., Deng, W., Yang, L., Tang, C., Yue, J.-M., Monteiro, O., Baptista‐Hon, D. T., & Li, T. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02357-x · Cited by 51 · see citing works

The Role of Apolipoproteins in the Commonest Cancers: A Review

Darwish, N. M., Al‐Hail, M., Mohamed, Y. H., Al-Saady, R., Mohsen, S., Zar, A., Al-Mansoori, L., & Pedersen, S. (2023) · Cancers · doi:10.3390/cancers15235565 · Cited by 40 · see citing works

Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis

More, S., Bonnereau, J., Wouters, D., Spotbeen, X., Karras, P., Rizzollo, F., Killian, T., Venken, T., Naulaerts, S., Vervoort, E., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp6164 · Cited by 25 · see citing works

A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors

Halder, A., Biswas, D., Chauhan, A., Saha, A., Auromahima, S., Yadav, D., Nissa, M. U., Iyer, G., Parihari, S., Sharma, G., et al. (2023) · Clinical Proteomics · doi:10.1186/s12014-023-09426-9 · Cited by 12 · see citing works

The tumor microenvironment shapes gastric cancer progression by coordinating immune suppression and metabolic reprogramming

Jiao, F., Wang, Z., Yuan, J., Shi, F., & Zhang, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1787060 · Cited by 11 · see citing works

Secretome and Proteome of Extracellular Vesicles Provide Protein Markers of Lung and Colorectal Cancer

Soloveva, N. A., Novikova, S. E., Farafonova, T. E., Tikhonova, O. V., & Zgoda, V. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031016 · Cited by 10 · see citing works

Delineating the intricacies of polymorphisms, structures, functions and therapeutic applications of biological high-density lipoprotein-apolipoprotein M: A review

Yadav, R., Obinata, H., & Venkataraman, K. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143187 · Cited by 8 · see citing works

Role and Diagnostic Significance of Apolipoprotein D in Selected Neurodegenerative Disorders

Kolanek, A., Cemaga, R., & Maciejczyk, M. (2024) · Diagnostics · doi:10.3390/diagnostics14242814 · Cited by 6 · see citing works

Apolipoprotein H-based prognostic risk correlates with liver lipid metabolism disorder in patients with HBV-related hepatocellular carcinoma

Liu, Y., Wu, Z., Zhao, Y., Zhen, M., Wang, Y., & Liu, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31412 · Cited by 6 · see citing works

ESCRT may function as a tumor biomarker, transitioning from pan-cancer analysis to validation within breast cancer

Chen, X., Tan, X., Zhang, Z.-L., Yuan, J., & Song, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1531940 · Cited by 6 · see citing works

Sesamin regulates breast cancer through reprogramming of lipid metabolism

Patil, P. H., Chaudhary, A., Bhandare, V. V., Patil, V. S., Beerwala, F. A., Karoshi, V., Sonawane, K. D., Mali, A. V., & Kaul-Ghanekar, R. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2333991 · Cited by 6 · see citing works

Mechanisms and applications of apolipoproteins and apolipoprotein mimetic peptides: Common pathways in cardiovascular disease and cancer

Delk, S. C., Gurgis, F. W., & Reddy, S. T. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.006 · Cited by 6 · see citing works

O-glycoprofiling of Serum Apolipoprotein C-III in Colorectal Cancer

Kianičková, K., Pakanová, Z., Květoň, F., Holazová, A., Kundalia, P. H., Baráth, P., Miljuš, G., Nedić, O., & Katrlı́k, J. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2901032 · Cited by 5 · see citing works

The adipocyte apolipoprotein M is negatively associated with inflammation

Frances, L., Croyal, M., Pittet, S., Fernandes, L. D. C., Boulaire, M., Monbrun, L., Blaak, E. E., Christoffersen, C., Moro, C., Tavernier, G., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100648 · Cited by 5 · see citing works

ZKSCAN5 transcriptional regulation of APOC1 modulates ferroptosis via PI3K/AKT/SREBP2/SLC1A5 axis

Liu, Y., Qi, Z., Yang, S., Li, Y., & Guo, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07092-z · Cited by 4 · see citing works

Exploring Canine Mammary Cancer through Liquid Biopsy: Proteomic Profiling of Small Extracellular Vesicles

Novais, A. A., Tamarindo, G. H., Melo, L. M. M., Balieiro, B. C., Nobrega, D., dos Santos, G., Saldanha, S. F., de Souza, F. F., Chuffa, L. G. D. A., Bracha, S., et al. (2024) · Cancers · doi:10.3390/cancers16142562 · Cited by 4 · see citing works

Apolipoproteins have a major role in cellular tumor dormancy in triple negative breast cancer: In-silico study

El-Gammal, Z., Bakry, U., El-Sayed, A. F., Ahmed, T. A., Oura, G. A., Elshenawy, S. E., El‐Badri, N., Romany, A. F., Amer, K., Elnagdy, T. R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71522-z · Cited by 4 · see citing works

Modulation of the replication of positive-sense RNA viruses by the natural plant metabolite xanthohumol and its derivatives

Marongiu, L., Burkard, M., Helling, T., Biendl, M., & Venturelli, S. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2275169 · Cited by 4 · see citing works

Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics

Whitham, D., Bruno, P. S., Haaker, N., Arcaro, K. F., Pentecost, B. T., & Darie, C. C. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2320158 · Cited by 4 · see citing works

Apolipoprotein B/Apolipoprotein A1 ratio is an independent prognostic factor in pancreatic cancer

Li, C., Yang, X., Zhong, Y., Wang, W., Jin, X., Bian, L., & Wang, X. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102208 · Cited by 3 · see citing works

APOC1, transcriptionally regulated by FOXM1, promotes M2 macrophage polarization and cervical cancer progression

Chai, Q., Qi, Y., Nie, X., & Wang, H. (2025) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2025.111904 · Cited by 3 · see citing works

The roles, signalling pathways and therapeutic implications of Apoc1 in cancer

Guo, H.-H., Guo, Q., Zhang, Q.-X., Li, D., & Lv, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-02313-9 · Cited by 3 · see citing works

Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapy

Rui, M., Fang, L., Jia, M., Liang, W., Li, Y., Ruan, Y., & Feng, C. (2025) · Drug Delivery · doi:10.1080/10717544.2025.2604086 · Cited by 3 · see citing works

Conserved Pathways, Divergent Outcomes: A Cross-Species Genomic Perspective on the Cancer–Neurodegeneration Paradox

Rajarathinam, B., Nandan, D., Venugopal, P., Nair, A. M., John, S., Nair, B. G., & Aradhya, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072989 · Cited by 3 · see citing works

Exploring the protein signature of endometrial cancer: A comprehensive review through diverse samples and mass spectrometry-based proteomics

Yildirim, O. S., Yıldız, P., Karaer, A., Calleja‐Agius, J., & Özcan, S. (2024) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2024.108783 · Cited by 3 · see citing works

Proteomic Profiling of Endometrial Cancer Tissues Reveals Differential Expression of Proteomes in Obese Versus Non-Obese Patients

Akkour, K., Rafiullah, M., Alfadda, A. A., Alanazi, I. O., Masood, A., Joy, S. S., Al-Eidan, A. A., Alshehri, E., Bassi, A., Alhalal, H., et al. (2026) · Cells · doi:10.3390/cells15060498 · Cited by 2 · see citing works

Proteomic analysis of holocarboxylase synthetase deficient-MDA-MB-231 breast cancer cells revealed the biochemical changes associated with cell death, impaired growth signaling, and metabolism

Sukjoi, W., Young, C., Acland, M., Siritutsoontorn, S., Roytrakul, S., Klingler‐Hoffmann, M., Hoffmann, P., & Jitrapakdee, S. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1250423 · Cited by 2 · see citing works

Identification of phenomic data in the pathogenesis of cancers of the gastrointestinal (GI) tract in the UK biobank

Tan, S. H., Guan, C. A., Bujang, M. A., Lai, W. H., Voon, P. J., & Sim, E. U. (2024) · Scientific Reports · doi:10.1038/s41598-024-52421-9 · Cited by 2 · see citing works

Two Sides of the Same Coin: Genes Involved in Neurodegeneration and Cancer

Montanari, M., Meringolo, M., Atiallah, I. E., Renna, A., & Martella, G. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_216 · Cited by 1 · see citing works

Evidence from Mendelian randomization analysis combined with meta-analysis for the causal validation of the relationship between 35 blood and urine metabolites and lumbar disc herniation

Yang, J., Xu, W., Chen, D., Yang, H., & Zhou, Z. P. (2025) · Medicine · doi:10.1097/md.0000000000042749 · Cited by 1 · see citing works

Potential of Serum ApoC1 as a Noninvasive Biomarker for Breast Cancer Detection and Prognosis: A Prospective Case–Control Study

Khalafi‐Nezhad, A., Barazesh, M., Abdollahi, A., Kheiri, N., & Amani, M. (2025) · Cancer Reports · doi:10.1002/cnr2.70359 · Cited by 1 · see citing works

Age-diet interactions significantly influence intratumoral gene expression, gut microbiome signature and tumor microenvironment in colorectal cancer

Soni, S., Mittal, P., Lo, J. H., Yang, Y., Smbatyan, G., Lee, K., Wan, J., Kumagai, H., Yen, K., Mehta, H. H., et al. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101245 · Cited by 1 · see citing works

Apolipoprotein B/Apolipoprotein A ratio: a novel prognostic factor for pancreatic cancerPreprint

Li, C., Yang, X., Zhong, Y., Wang, W., Jin, X., Bian, L., & wang, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2823601/v1

Identification of phenomic data in the pathogenesis of cancers of the gastrointestinal (GI) tract: A UK biobank data analysisPreprint

Tan, S. H., Guan, C. A., Bujang, M. A., Lai, W. H., Voon, P. J., & Sim, E. U. (2023) · Research Square · doi:10.21203/rs.3.rs-3251414/v1

DIGEST: An online tool for designing of multiple reaction monitoring assaysPreprint

Gautam, P., Singh, P., Mrinal, Bhaskar, A. K., Sacher, S., Dagar, Y., Basak, T., Sengupta, S., & Ray, A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.27.568790

Intergalactic Interactions - Network Biology in Rodents from Spaceflight and Terra FirmaPreprint

Hacking, S. M., & Sargin, Z. E. (2023) · Research Square · doi:10.21203/rs.3.rs-3711156/v1

Serum and urine apolipoprotien A1 (ApoA1) as biomarkers in bladder cancer

Kalaf, F. H., Rasheed, M. K., & Ismail, M. B. (2024) · Romanian Medical Journal · doi:10.37897/rmj.2024.2.11

Comparative Study of Cutaneous Squamous Cell Carcinogenesis in Different Hairless Murine Models

Gkikas, G., Katsiris, D., Vitsos, A., Gioran, A., Ieronymaki, D., Kostaki, M., Ladopoulos, G., Ioannidou, V., Theodoraki, E., Chondrogianni, N., et al. (2024) · Cancers · doi:10.3390/cancers16203546

Assessing the causal relationships between circulating metabolic biomarkers and breast cancer by using mendelian randomization

Wang, B., Ling, Y., Zhang, H., & Yang, M. W. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1448748

Apolipoproteins in Psoriasis: The Effect of Acitretin Treatment and UVB Phototherapy

Myśliwiec, H., Kozłowska, D., Hodun, K., Łukaszuk, B., Owczarczyk-Saczonek, A. B., Chabowski, A., & Flisiak, I. (2025) · Metabolites · doi:10.3390/metabo15030196

Cancer Specific Epigenetic Biomarker Extraction from DNA Methylation and Gene Expression Data

Panchami, V., Manish, T. I., & Manesh, K. K. (2025) · AI-Driven Smart Healthcare for Society 5.0 · doi:10.1109/ieeeconf64992.2025.10962874

Additional file 2 of A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors

Halder, A., Biswas, D., Chauhan, A., Saha, A., Auromahima, S., Yadav, D., Nissa, M. U., Iyer, G., Parihari, S., Sharma, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24217661

APOE ε2/ε3 is associated with multi-layered protection against prostate cancer in Chinese men

Wang, K., Zhang, S., Chen, M., Duan, X., Xie, Y., Yang, X., Zhong, Y., Pan, Y., Yang, M., Wei, Z., et al. (2026) · World Journal of Urology · doi:10.1007/s00345-026-06459-1

Deciphering the interplay between cuproptosis and mitochondrial energy metabolism in thyroid cancer: a multi-omics study for molecular subtyping, prognosis, and tumor microenvironment characterization

Le, H., Wu, Y., Wu, N., Jing, R., Zhou, X., Li, Y., Yi, S., & Zhang, H. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05604-z

Over-presentation of apolipoprotein E gene variants E3/E4 and cardiovascular disease risk factors among Ghanaian breast cancer patients

Antonio, D. N. M., Annani-Akollor, M. E., Fondjo, L. A., Anang-Quartey, Y., Owusu, H., Arko‐Boham, B., Santa, S. A., Quaye, O., & Tagoe, E. A. (2026) · BMC Cancer · doi:10.1186/s12885-026-16354-y

Variable selection-combined causal mediation analysis for continuous treatments with application to large-dimensional biomedical data

Zhou, Y., Wei, K., Liu, Y., Li, Z., (202847), C. H., Qin, G., & Yu, Y. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014436

Apolipoprotein E and its role in cancer: Insight into carcinogenic associations

Das, S. R., Sudha, T., Ahmad, S., Puri, P., Bajpai, C. K., Aziz, N., & Kumar, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00006-5

Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma

Kött, J., Geidel, G., Roeper, C. M. T., Ačkar, L., Siebels, B., Voß, H., Schlüter, H., Schweizer, M., Müller, K., Rünger, A., et al. (2026) · International Journal of Cancer · doi:10.1002/ijc.70650

Hallachrome, a marine anthraquinone, impairs cell proliferation by acting as a functional mitochondrial uncoupler in A375 melanoma cells

Lofaro, F. D., Ferri, A., Mazzilli, A., Bonacorsi, S., Simonini, R., & Boraldi, F. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1844144

Leveraging endogenous proteins to improve cancer nanomedicine delivery

Xu, Z., Jolly, K. J., & Zhang, F. (2026) · Nanoscale · doi:10.1039/d6nr01492e

Nano-bioelectronic Immunosensing Platform Integrated with Personalized Data Analytics for APO-A1 Evaluation in Human Serum

Kumari, R., Dubey, R., & Chandra, P. (2026) · ACS Applied Electronic Materials · doi:10.1021/acsaelm.6c00728

Antitumor activity of high-density lipoproteins and their use for targeted drug delivery

Poteryaeva, O. N., Викторовна, Т. Н., & Федорович, У. И. (2026) · Biomeditsinskaya Khimiya · doi:10.18097/pbmcr1720

APOC1 ‐Associated VLDL ‐Pathway Dysregulation in Papillary Thyroid Carcinoma: A Reproducible Cross‐Cohort Transcriptomic Signature Associated With the Diagnostic‐to‐Treatment Interval

Li, Y., Meng, G., Peng, M., Chen, G., & Zhang, Y. (2026) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70403

The Role of Apolipoproteins in the Commonest Cancers: A Review

Darwish, N. M., Al‐Hail, M., Mohamed, Y. H., Al-Saady, R., Mohsen, S., Zar, A., Al-Mansoori, L., & Pedersen, S. (2023) · Cancers · doi:10.3390/cancers15235565 · Cited by 40 · see citing works

Apolipoproteins and cancer

Ren, L., Yi, J., Li, W., Zheng, X., Liu, J., Wang, J., & Du, G. (2019) · Cancer Medicine · doi:10.1002/cam4.2587 · Cited by 145 · see citing works

Apolipoprotein: prospective biomarkers in digestive tract cancer

Zhang, Y., & Zheng, L. (2020) · Translational Cancer Research · doi:10.21037/tcr-19-2106 · Cited by 20 · see citing works

Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer

Zhou, Y., & Luo, G. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02354-2 · Cited by 59 · see citing works

Genomic and transcriptomic alterations of apolipoproteins genes in cancers

Swadi, K. H. (. (2023) · University of Southern California Digital Library · doi:10.25549/usctheses-ouc113302375